UNSPSC 51112508: Bendamustine hydrochloride

This classification denotes a nitrogen mustard compound with the molecular formula C16H21Cl2N3O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 981Y8SX18M, chemically known as 2-benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride but more generally known as bendamustine hydrochloride, which bears US NIH Compound Identifier 77082. The base compound, Bendamustine, most often comes in base and hydrochloride forms.

UNSPSC 51112508 Bendamustine hydrochloride is a Commodity code for a specific chemotherapy agent used in cancer treatment protocols. State and local governments procure this pharmaceutical through health agencies, Medicaid programs, and public health systems that serve covered populations. The code encompasses the acquisition of this branded or generic cytotoxic medication for direct dispensing to eligible patients under state or local pharmacy benefit programs. Issuing bodies soliciting under this code are primarily state health and human services departments managing pharmacy benefit programs and Medicaid formularies, though activity may also involve county health departments and municipal public health systems that operate treatment facilities or pharmacy operations.

The Texas Health and Human Services Commission posted Request for Information HHS0017013 on April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs that would establish relationships between the state's pharmacy benefit program and pharmaceutical manufacturers to improve prescription fulfillment and cost management. This RFI explored vendors' capacity to negotiate direct contracts with self-insured health plans and state agencies outside traditional pharmacy benefit manager and group purchasing organization channels, with interest in value-based or outcomes-based pricing models. The solicitation represents early-stage market research rather than a binding procurement commitment, designed to inform the state's future strategy before issuing a formal RFP. No specific contract value, award timeline, or set-aside designations were identified in the RFI materials. Beyond this Texas opportunity, the source supports no other recent state or local solicitations under this Commodity code.